ROBERT J. RUBIN, MD

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

SOLIGENIX, INC.

Filing Date Source Excerpt
2011-05-10 From January 2010 through September 2010, the Compensation Committee was comprised of Mr. Lapointe, Dr. Rubin and Mr. Buhrman. Since September 2010, the Compensation Committee has been comprised of Dr. Rubin, Ms. Howson and Mr. Thompson. ... From January 2010 through September 2010, the Nominating Committee was comprised of Mr. Lapointe, Dr. Rubin and Mr. Buhrman. Since September 2010, the Nominating Committee has been comprised of Mr. Lapointe, Dr. Rubin and Ms. Howson. ... From January 2010 through September 2010, the Audit Committee was comprised of Mr. Lapointe, Dr. Rubin and Mr. Buhrman. Since September 2010, the Audit Committee has been comprised of Messrs. Lapointe and Thompson and Dr. Rubin. ... Robert J. Rubin, MD has been a director since October 2009.
2013-08-14 Robert J. Rubin, MD has been a director since October 2009. The Board of Directors has an Audit Committee, which is comprised of Mr. Brownlie (Chair), Mr. Lapointe and Dr. Rubin. The Compensation Committee is comprised of Dr. Rubin (Chair), Mr. Brownlie and Dr. Zeldis. The following table contains information concerning the compensation of the non-employee directors during the fiscal year ended December 31, 2012. Robert J. Rubin received $54,375 in fees and $7,500 in option awards, totaling $61,875.
2014-05-08 Robert J. Rubin, MD has been a director since October 2009... The Board of Directors has the following three committees: (1) Compensation, (2) Audit and (3) Nominating and Corporate Governance... Robert J. Rubin - Audit Committee, Compensation Committee (Chair)... Compensation of Directors: Robert J. Rubin - Fees Earned Paid in Cash $52,500, Option Awards $30,000, Total $82,500.
2015-05-01 Robert J. Rubin, MD has been a director since October 2009. Dr. Rubin was selected to serve as a member of our Board of Directors because of his vast experience in the health care industry... The Compensation Committee is comprised of Dr. Rubin (Chair), Dr. Brughera and Dr. Zeldis.
2016-05-02 Robert J. Rubin, MD has been a director since October 2009... The Compensation Committee is comprised of Dr. Rubin (Chair), Dr. Brughera and Dr. Zeldis... The Audit Committee is comprised of Mr. Brownlie (Chair), Mr. Lapointe and Dr. Rubin... Compensation of Directors: Robert J. Rubin Fees Earned Paid in Cash $52,500, Option Awards $30,000, Total $82,500.
2017-04-28 Robert J. Rubin, MD has been a director since October 2009... The Audit Committee is comprised of Mr. Brownlie (Chair), Mr. Lapointe and Dr. Rubin... The Compensation Committee is comprised of Dr. Rubin (Chair), Dr. Brughera and Dr. Zeldis... The following table contains information concerning the compensation of the non-employee directors during the fiscal year ended December 31, 2016. Robert J. Rubin Fees Earned Paid in Cash $52,500 Option Awards $30,000 Total $82,500.
2018-08-10 Robert J. Rubin, MD 72 Director
2019-07-26 Robert J. Rubin, MD has been a director since October 2009. Our Board of Directors has an Audit Committee, which is comprised of Mr. Brownlie (Chair), Mr. Lapointe and Dr. Rubin. Our Board of Directors has a Compensation Committee, which is comprised of Dr. Rubin (Chair), Mr. Pearson and Dr. Zeldis. The following table contains information concerning the compensation of the non-employee directors during the year ended December 31, 2018. Robert J. Rubin: Fees Earned Paid in Cash: $52,500, Option Awards: $30,000, Total: $82,500.
2020-08-07 Robert J. Rubin, MD has been a director since October 2009. ... Our Board of Directors has an Audit Committee, which is comprised of Mr. Lapointe (Chair), Ms. Parks and Dr. Rubin. ... Our Board of Directors has a Compensation Committee, which is comprised of Dr. Rubin (Chair), Mr. Lapointe and Dr. Zeldis.
2021-08-10 Robert J. Rubin, MD has been a director since October 2009. ... Our Board of Directors has an Audit Committee, which is comprised of Mr. Lapointe (Chair), Ms. Parks and Dr. Rubin. ... Our Board of Directors has a Compensation Committee, which is comprised of Dr. Rubin (Chair), Mr. Lapointe and Dr. Zeldis. ... Compensation of Directors table shows Robert J. Rubin earned $52,500 in cash and $30,000 in option awards for a total of $82,500 in 2020.
2022-08-05 Robert J. Rubin, MD has been a director since October 2009. Dr. Rubin was a clinical professor of medicine at Georgetown University from 1995 until 2012 when he was appointed a Distinguished Professor of Medicine. From 1987 to 2001, he was president of the Lewin Group (purchased by Quintiles Transnational Corp. in 1996), an international health policy and management consulting firm. From 1994 to 1996, Dr. Rubin served as Medical Director of ValueRx, a pharmaceutical benefits company. From 1992 to 1996, Dr. Rubin served as President of Lewin-VHI, a health care consulting company. From 1987 to 1992, he served as President of Lewin-ICF, a health care consulting company. From 1984 to 1987, Dr. Rubin served as a principal of ICF, Inc., a health care consulting company. From 1981 to 1984, Dr. Rubin served as the Assistant Secretary for Planning and Evaluation at the Department of Health and Human Services and as an Assistant Surgeon General in the U.S. Public Health Service. Dr. Rubin has served on the Board of BioTelemetry, Inc. (formerly known as CardioNet, Inc.) from 2007 to February 2021. He is a board-certified nephrologist and internist. Dr. Rubin received an undergraduate degree in Political Science from Williams College and his medical degree from Cornell University Medical College.
2023-08-07 Dr. Rubin received an undergraduate degree in Political Science from Williams College and his medical degree from Cornell University Medical College.
2024-04-29 Robert J. Rubin, MD has been a director since October 2009. Dr. Rubin was a clinical professor of medicine at Georgetown University. The Audit Committee includes Dr. Rubin. The Compensation Committee is chaired by Dr. Rubin. The Nominating and Corporate Governance Committee includes Dr. Rubin.

Data sourced from SEC filings. Last updated: 2026-02-03